Cancer Research Institute
Overview
The Cancer Research Institute is a non-profit organization founded in 1953 dedicated to advancing cancer immunotherapy. While its primary activities involve funding research grants, fellowships, and clinical trials, it also makes early-stage equity investments in private biotech companies. This investment activity is conducted through a venture philanthropy model, including the CRI Venture Fund and the Anna-Maria Kellen Clinical Accelerator. The goal of these investments is to support companies aligned with CRI's mission, often those founded by or involving scientists from its global network. The institute participated in the $16 million seed funding for OverT Bio in May 2024.
Portfolio Companies
7
Website
cancerresearch.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OverT Bio | May 2024 | Seed | Co-investor |
| Pilatus Biosciences | Dec 2025 | Pre Seed | Co-investor |
| Cartography Biosciences | Jul 2022 | Series A | Co-investor |
| Infinitopes Precision Immunomics | Jan 2026 | Seed | Co-investor |
| SURGE Therapeutics | Jul 2023 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cancer Research Institute based?
Cancer Research Institute is headquartered in New York City, New York, United States.
When was Cancer Research Institute founded?
Founding year information for Cancer Research Institute is not publicly available.
How many portfolio companies does Cancer Research Institute have?
Cancer Research Institute has 7 portfolio companies in Caplight's dataset.
What are some companies in Cancer Research Institute's portfolio?
Portfolio companies visible on Caplight include OverT Bio, Pilatus Biosciences, Cartography Biosciences, Infinitopes Precision Immunomics, SURGE Therapeutics.
What was Cancer Research Institute's most recent investment shown here?
Cancer Research Institute's most recent investment in this portfolio sample was in Infinitopes Precision Immunomics in 2026.
What sectors does Cancer Research Institute focus on?
Cancer Research Institute focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Cancer Research Institute focus on?
Cancer Research Institute typically invests at the Early stage.
What is Cancer Research Institute's AUM?
Cancer Research Institute's assets under management are estimated between $134.0M and $134.0M.